Oxidase Inhibitors were among the first drugs widely used for the
treatment of major depression.
Their action helped
prove the monoamine hypothesis of depression.
While they are a highly
effective treatment, dietary restrictions, overdose risks and
increasing specialization of chemical action in the newer
anti-depressants has relegated them to a last resort in the hierarchy
of pharmalogical treatments